Study for treatment of resected stage III colon cancer

Primary disease category: Cancer

Secondary disease categories: Colorectal Cancer

Sponsor: Southwest Oncology Group

Protocol number: C80702

Projected enrollment dates: January 2014 to February 2017

Official study title: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer